JP7730563B2 - ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法 - Google Patents

ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法

Info

Publication number
JP7730563B2
JP7730563B2 JP2022538023A JP2022538023A JP7730563B2 JP 7730563 B2 JP7730563 B2 JP 7730563B2 JP 2022538023 A JP2022538023 A JP 2022538023A JP 2022538023 A JP2022538023 A JP 2022538023A JP 7730563 B2 JP7730563 B2 JP 7730563B2
Authority
JP
Japan
Prior art keywords
cell line
immortalized
pam
cultured
alveolar macrophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022538023A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022019306A5 (https=
JPWO2022019306A1 (https=
Inventor
真 小澤
結子 菅谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kagoshima University NUC
Original Assignee
Kagoshima University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kagoshima University NUC filed Critical Kagoshima University NUC
Publication of JPWO2022019306A1 publication Critical patent/JPWO2022019306A1/ja
Publication of JPWO2022019306A5 publication Critical patent/JPWO2022019306A5/ja
Application granted granted Critical
Publication of JP7730563B2 publication Critical patent/JP7730563B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • C07K14/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006Modification of the membrane of cells, e.g. cell decoration
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2022538023A 2020-07-22 2021-07-20 ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法 Active JP7730563B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020125310 2020-07-22
JP2020125310 2020-07-22
PCT/JP2021/027164 WO2022019306A1 (ja) 2020-07-22 2021-07-20 ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法

Publications (3)

Publication Number Publication Date
JPWO2022019306A1 JPWO2022019306A1 (https=) 2022-01-27
JPWO2022019306A5 JPWO2022019306A5 (https=) 2023-06-13
JP7730563B2 true JP7730563B2 (ja) 2025-08-28

Family

ID=79729168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538023A Active JP7730563B2 (ja) 2020-07-22 2021-07-20 ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法

Country Status (2)

Country Link
JP (1) JP7730563B2 (https=)
WO (1) WO2022019306A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117487761A (zh) * 2023-09-25 2024-02-02 南京农业大学 表达Cre基因猪骨髓巨噬细胞系的构建方法及其应用
WO2025182870A1 (ja) * 2024-02-26 2025-09-04 国立研究開発法人農業・食品産業技術総合研究機構 不死化カワイノシシマクロファージ
CN118389443A (zh) * 2024-04-25 2024-07-26 上海交通大学 猪GSDMD敲除细胞系的构建方法及在PDCoV感染中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017500029A (ja) 2013-12-12 2017-01-05 インターベット インターナショナル ベー. フェー. 不死化ブタ肺胞マクロファージ
CN109517797A (zh) 2018-07-25 2019-03-26 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 表达猪繁殖障碍与呼吸综合症病毒受体cd163的猪永生化肺泡巨噬细胞细胞系及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017500029A (ja) 2013-12-12 2017-01-05 インターベット インターナショナル ベー. フェー. 不死化ブタ肺胞マクロファージ
CN109517797A (zh) 2018-07-25 2019-03-26 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 表达猪繁殖障碍与呼吸综合症病毒受体cd163的猪永生化肺泡巨噬细胞细胞系及其应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Dev. Comp. Immunol.,2018年,Vol. 79,p. 51-58
J. Virol. Methods,2002年,Vol. 104,pp. 203-216
Oncotarget,2018年,Vol. 9, No. 15,pp. 12174-12185

Also Published As

Publication number Publication date
WO2022019306A1 (ja) 2022-01-27
JPWO2022019306A1 (https=) 2022-01-27

Similar Documents

Publication Publication Date Title
JP7730563B2 (ja) ブタ肺胞マクロファージ不死化培養細胞株、ブタ肺胞マクロファージ不死化培養細胞株の製造方法、ブタ肺胞マクロファージ不死化培養細胞株の調製用試薬及びワクチンの製造方法
KR102423444B1 (ko) 레트로바이러스 벡터
US12343390B2 (en) Recombinant biologically contained filovirus vaccine
Carnero et al. Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses
JP6916209B2 (ja) 特に免疫応答に関与する細胞への、rnaの転移のためのウイルス粒子
RU2729385C2 (ru) Биопроизводство лентивирусных векторов
Carpenter et al. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus
Uhlig et al. Lentiviral protein transfer vectors are an efficient vaccine platform and induce a strong antigen-specific cytotoxic T cell response
EP2636413A1 (en) Chimeric virus-like particles (VLP) containing functional hMPV proteins
US9879230B2 (en) Chimeric non-integrating lentiviral genomes as vaccines against HIV-1
US12286639B2 (en) LDLR negative packaging cell line for the production of VSV-G pseudotyped retroviral vector particles or virus particles thereof
WO2023072178A1 (en) Methods for developing a cell line for producing virus in suspension cell culture
WO2012038832A2 (en) Generation of replicating chimeric measles virus - retrovirus particles
KR101201240B1 (ko) 돼지생식기호흡기증후군 바이러스 분리를 위한 PAM-pCD163세포주 및 이를 이용한 백신
US20220228169A1 (en) Small ruminant lentivirus vector
US7964341B2 (en) Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof
EP3604502B1 (en) Stable production of virulent enterovirus 71 and use thereof
WO2010009465A2 (en) Htlv-ii vector and methods of use
JP4649145B2 (ja) ワクチン製造用株化細胞およびウイルス
JP2001097885A (ja) ネコ・レトロウイルスワクチン、およびその調製方法
Fu et al. Development and Application of Respiratory Pseudovirus Packaging System
Makarova et al. Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model
CN120249228A (zh) 具有转录和复制能力的Sindbis病毒样颗粒trVLP-ASV及应用
US20210388384A1 (en) Vectors
Pépin et al. Maedi visna

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20220930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220930

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240705

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250808

R150 Certificate of patent or registration of utility model

Ref document number: 7730563

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150